# EDGAR Filing Document

**Accession Number:** 0001830214
**File Stem:** 0001193125-23-039326
**Filing Date:** 2023-2
**Character Count:** 11016
**Document Hash:** dfb7aaebefa4f835a12bf12f7ea00c3f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-039326.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001193125-23-039326

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Ginkgo Bioworks Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001830214
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 872652913
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92710
- **FILM NUMBER:** 23631192

**BUSINESS ADDRESS:**
- **STREET 1:** 27 DRYDOCK AVENUE
- **STREET 2:** 8TH FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210
- **BUSINESS PHONE:** (877) 442-5362

**MAIL ADDRESS:**
- **STREET 1:** 27 DRYDOCK AVENUE
- **STREET 2:** 8TH FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Soaring Eagle Acquisition Corp.
- **DATE OF NAME CHANGE:** 20210210

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Spinning Eagle Acquisition Corp.
- **DATE OF NAME CHANGE:** 20201027
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Knight Thomas F. Jr.
- **CENTRAL INDEX KEY:** 0001885249

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**MAIL ADDRESS:**
- **STREET 1:** C/O GINKGO BIOWORKS, INC.
- **STREET 2:** 27 DRYDOCK AVENUE, 8TH FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210

------

------

**Securities and Exchange Commission** 

**Washington, D.C. 20549** 

------

**Schedule 13G** 

**(Rule 13d-102)**

**Information to be Included in Statements Filed Pursuant** 

**to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed** 

**Pursuant to § 240.13d-2**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934** 

**(Amendment No. 2)\*** 

------

## Ginkgo Bioworks Holdings, Inc.
**(Name of Issuer)** 

**Class A Common Stock** 

**(Title of Class of Securities)** 

**37611X100** 

**(CUSIP Number)** 

**December 31, 2022** 

**(Date of Event Which Requires Filing of this Statement)** 

------

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

\* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

------

CUSIP No. 37611X100 Schedule 13G Page 2 of 6

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp;&nbsp;Names of Reporting Persons<br>&nbsp;&nbsp;&nbsp;&nbsp;Thomas F. Knight Jr. |
| &nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;Check the Appropriate Box if a Member of a Group<br>&nbsp;&nbsp;&nbsp;&nbsp;(a) ☐ (b) ☐ |
| &nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp;SEC Use Only |
| &nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;Citizenship or Place of Organization<br>&nbsp;&nbsp;&nbsp;&nbsp;United States |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 5 | &nbsp;&nbsp;&nbsp;&nbsp;Sole Voting Power<br>&nbsp;&nbsp;&nbsp;&nbsp;33,477,356 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 6 | &nbsp;&nbsp;&nbsp;&nbsp;Shared Voting Power<br>&nbsp;&nbsp;&nbsp;&nbsp;41,458,760 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 7 | &nbsp;&nbsp;&nbsp;&nbsp;Sole Dispositive Power<br>&nbsp;&nbsp;&nbsp;&nbsp;33,477,356 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With | 8 | &nbsp;&nbsp;&nbsp;&nbsp;Shared Dispositive Power<br>&nbsp;&nbsp;&nbsp;&nbsp;41,458,760 |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 9 | &nbsp;&nbsp;&nbsp;&nbsp;Aggregate Amount Beneficially Owned by Each Reporting Person<br>&nbsp;&nbsp;&nbsp;&nbsp;74,936,116 |
| &nbsp;&nbsp;&nbsp;10 | &nbsp;&nbsp;&nbsp;&nbsp;Check if the Aggregate Amount in Row (9) Excludes Certain Shares<br>&nbsp;&nbsp;&nbsp;&nbsp;Not Applicable |
| &nbsp;&nbsp;&nbsp;11 | &nbsp;&nbsp;&nbsp;&nbsp;Percent of Class Represented by Amount in Row 9<br>&nbsp;&nbsp;&nbsp;&nbsp;5.0% |
| &nbsp;&nbsp;&nbsp;12 | &nbsp;&nbsp;&nbsp;&nbsp;Type of Reporting Person<br>&nbsp;&nbsp;&nbsp;&nbsp;IN |

---

------

CUSIP No. 37611X100 Schedule 13G Page 3 of 6

---

| | |
|:---|:---|
| **ITEM 1. (a)** | **Name of Issuer:**  |

---

Ginkgo Bioworks Holdings, Inc. (the "Issuer").

**(b) Address of Issuer's Principal Executive Offices:** 

27 Drydock Avenue, 8th Floor, Boston, MA 02210.

---

| | |
|:---|:---|
| **ITEM 2. (a)** | **Name of Person Filing:**  |

---

Thomas F. Knight Jr. (the "Reporting Person").

**(b) Address or Principal Business Office:** 

The business address of the Reporting Person is c/o Ginkgo Bioworks Holdings, Inc., 27 Drydock Avenue, 8th Floor, Boston, MA 02210.

**(c) Citizenship of each Reporting Person is:** 

The Reporting Person is a citizen of the United States.

**(d) Title of Class of Securities:** 

Class A common stock, par value $0.0001 per share ("Class A Common Stock").

**(e) CUSIP Number:** 

37611X100

**ITEM 3.**

Not applicable.

---

| | |
|:---|:---|
| **ITEM 4.** | **Ownership.**  |

---

**(a-c)**

The ownership information presented below represents beneficial ownership of Class A Common Stock of the Issuer as of December 31, 2022, based upon 1,485,254,982 shares of Class A Common Stock outstanding as of February 10, 2023 and 8,972,183 shares of Class A Common Stock issuable upon conversion of shares of Class B common stock, $0.0001 per share, of the Issuer ("Class B Common Stock") owned by the Reporting Person.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Amount beneficially owned: 74,936,116

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Percent of Class: 5.0%

------

CUSIP No. 37611X100 Schedule 13G Page 4 of 6

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Number of shares the Reporting Person has:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Sole power to vote or direct the vote: 33,477,356

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Shared power to vote: 41,458,760

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Sole power to dispose or direct the disposition of: 33,477,356

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Shared power to dispose or direct the disposition of: 41,458,760

The share amount reported herein consists of

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) 24,505,173 shares of Class A Common Stock held of record by the Reporting Person;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) 8,972,183 shares of Class A Common Stock issuable upon conversion of shares of Class B Common Stock
held of record by the Reporting Person;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) 35,293,804 shares of Class A Common Stock held of record by The Knight Family Trust dated August 20, 2019 of
which Peter P. Brown, James Yost Knight, and Elizabeth June Knight are co-trustees (the "Family Trust");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) 4,468,287 shares of Class A Common Stock held of record by The Knight Family Trust – Marital Share dated
March 2, 2021 of which Peter P. Brown, James Yost Knight, and Elizabeth June Knight are co-trustees (the "Family Trust—Marital Share"); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) 1,696,669 shares of Class A Common Stock held of record by The Thomas F. Knight Jr. Grantor Retained Annuity
Trust (2) dated December 16, 2020 (the "GRAT") of which the Reporting Person and Peter P. Brown are co-trustees.

The Reporting Person has the power to withdraw the shares of Class A Common Stock held in the Family Trust and Family Trust—Marital Share in exchange for assets of equivalent value at his sole discretion and for his sole benefit. As such, the Reporting Person may be deemed to share beneficial ownership over the shares held of record by the Family Trust and Family Trust—Marital Share. The Reporting Person serves as co-trustee for the GRAT. As such, the Reporting Person may be deemed to share beneficial ownership over the shares held of record by the GRAT. The shares of Class B Common Stock may be redeemed by the holder at any time for shares of Class A Common Stock on a one-to-one basis.

The reported share amount excludes 5,496,994 shares held in trusts the beneficiaries of which are members of the Reporting Person's family because the Reporting Person does not have voting or dispositive power over shares held by those trusts or the ability to obtain voting or dispositive power within 60 days.

---

| | |
|:---|:---|
| **ITEM 5.** | **Ownership of Five Percent or Less of a Class.**  |

---

Not applicable.

---

| | |
|:---|:---|
| **ITEM 6.** | **Ownership of More Than Five Percent on Behalf of Another Person.**  |

---

Not applicable.

------

CUSIP No. 37611X100 Schedule 13G Page 5 of 6

---

| | |
|:---|:---|
| **ITEM 7.** | **Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company.**  |

---

Not applicable.

---

| | |
|:---|:---|
| **ITEM 8.** | **Identification and Classification of Members of the Group.**  |

---

Not applicable.

---

| | |
|:---|:---|
| **ITEM 9.** | **Notice of Dissolution of Group.**  |

---

Not applicable.

---

| | |
|:---|:---|
| **ITEM 10.** | **Certification.**  |

---

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

------

CUSIP No. 37611X100 Schedule 13G Page 6 of 6

**SIGNATURE** 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Date**: February 14, 2023

---

| | |
|:---|:---|
| By: | /s/ Thomas F. Knight Jr. |
| Name: | Thomas F. Knight Jr. |

---